NEW YORK >> Purdue Pharma has won support from the attorneys general of 55 U.S. states and territories for its $7.4 billion settlement to resolve thousands of opioid lawsuits against the drugmaker and its owners, members of the Sackler family.
Georgia will join other states and U.S. territories in a settlement that extracts $7.4 billion from Purdue Pharma and its owners, the Sackler family, as recompense for their role in the opioid crisis that ravaged the country for a generation.
Purdue Pharma and Sackler family members who own the company have reached a $7.4 billion settlement with all 50 states and U.S. territories over the company's improper marketing of opioids.
The deal would be among the largest in a wave of opioid settlements. It calls for members of the Sackler family who own the company to give up ownership and to contribute up to $7 billion over time.
A historic and national $7.4 billion dollar settlement has been reached with Purdue Pharma, the maker of the opioid OxyContin that spurred a major start of the opioid epidemic. A prior settlement had been struck down by the Supreme Court.
If approved, the settlement would be among the largest in a wave of lawsuits over the past decade as governments and others sought to hold drugmakers, wholesalers and pharmacies accountable for the opioid epidemic that started rising in the years after OxyContin hit the market in 1996.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
All US states agree to $7.4 billion settlement with Purdue Pharma in opioid litigation | Since Then
